Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
about
MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors.Update on imatinib for gastrointestinal stromal tumors: duration of treatment.Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.Exploring novel therapeutic targets in GIST: focus on the PI3K/Akt/mTOR pathway.Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imagingPhase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.New targets and therapies for gastrointestinal stromal tumors.Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)
P2860
Q34957090-30BF47FF-2838-4AD7-8A72-405F532D41ADQ37075052-FEA52F21-C130-429A-87E9-E632BAEBD436Q37871191-9C084718-7590-491D-A70C-2B3FF31A21C7Q38100719-2BE7B011-EBA4-472C-9080-6C6907CE462BQ38268165-6E920139-9A36-4509-A7D5-17D06BDC70AAQ41963175-7FEDD32F-33A7-4FAE-9F12-12E2FEE189EAQ45357596-2914682F-ADC1-4CA0-B0EE-7FAA3718D84EQ47432725-FDC6FFF6-FC19-4319-AA4A-6F1A7ADC85E3Q54473967-91ECC0EE-16B0-45DB-AEF0-794A54D44C81Q58850447-3ABE1BC6-F053-4D51-86CC-CB5C596A55C7
P2860
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@ast
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@en
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@nl
type
label
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@ast
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@en
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@nl
prefLabel
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@ast
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@en
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@nl
P2093
P2860
P50
P356
P1476
Preclinical evaluation of KIT/ ...... rs using small animal FDG PET.
@en
P2093
Carmelo Quarta
Chiara Gnocchi
Cristina Nanni
Domenico Rubello
Elena Bellan
Giordano Nicoletti
Lorena Landuzzi
Mauro Castelli
Monica Di Battista
Paolo Castellucci
P2860
P2888
P356
10.1186/1756-9966-29-173
P577
2010-12-30T00:00:00Z
P5875
P6179
1033789235